Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Macrogenics (MGNX) over the last 10 years, with Q3 2025 value amounting to $66.3 million.

  • Macrogenics' Long-Term Investments rose 21954.87% to $66.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.3 million, marking a year-over-year increase of 21954.87%. This contributed to the annual value of $18.8 million for FY2024, which is 8538.83% down from last year.
  • Per Macrogenics' latest filing, its Long-Term Investments stood at $66.3 million for Q3 2025, which was up 21954.87% from $45.8 million recorded in Q2 2025.
  • Macrogenics' 5-year Long-Term Investments high stood at $166.5 million for Q3 2023, and its period low was $8.6 million during Q1 2025.
  • In the last 5 years, Macrogenics' Long-Term Investments had a median value of $103.9 million in 2024 and averaged $82.1 million.
  • Per our database at Business Quant, Macrogenics' Long-Term Investments soared by 49729.76% in 2024 and then plummeted by 9174.93% in 2025.
  • Macrogenics' Long-Term Investments (Quarter) stood at $120.1 million in 2021, then tumbled by 62.13% to $45.5 million in 2022, then skyrocketed by 183.18% to $128.8 million in 2023, then crashed by 85.39% to $18.8 million in 2024, then soared by 251.98% to $66.3 million in 2025.
  • Its last three reported values are $66.3 million in Q3 2025, $45.8 million for Q2 2025, and $8.6 million during Q1 2025.